Abstract:OBJECTIVE:Vectors commonly used for therapeutic angiogenesis such as adenovirus and plasmid had their own limitations. Adenovirus-associated virus (AAV) is a relatively new but probably more ideal vector as it is safe and efficient. We will study the efficiency of recombinant AAV-2 mediated vascular endothelial growth factor165 gene transfer in inducing angiogenesis and arteriogenesis, in improving blood flow and myocardium function in a porcine chronic myocardial ischemic model.METHODS:Chinese experimental minipigs underwent placement of a left circumflex artery aneroid constrictor. Five weeks later, electrocardiogram, coronary angiography and magnetic resonance imaging were performed to confirm occlusion of LCX or ischemia of myocardium in LCX territory. Coronary blood flow, myocardium perfusion and left ventricular wall function were also evaluated. Then the animals were randomized to treatment with rAAV2-VEGF(165) (1 x 10(12) virus genome) or administration of PBS, both by direct myocardial injection. Three and six months after therapy, the animals were evaluated with regard to expression of VEGF(165) Capillary density and arteriole density of the ischemic myocardium, coronary angiography, myocardial perfusion and left ventricular function were also assessed six months after therapy.RESULTS:Five weeks after aneroid occluder implantation, all the animals demonstrated complete or nearly complete occlusion of LCX and perfusion deficiency in LCX territory. Three months after therapy, expression of VEGF(165) mRNA and protein were higher in the VEGF than control group. The difference between the two groups diminished after six months. There was significant increase in capillary density (1404.06 +/- 250.48/mm(2) vs 976.88 +/- 344.79/mm(2), P < 0.05) and arteriole density (167.81 +/- 36.29/mm(2) vs 116.56 +/- 34.48/mm(2), P < 0.05) in VEGF group compared with control. Comparison of myocardial perfusion demonstrated marked differences between the two groups with significant improvement in animals treated with rAAV2-VEGF(165). No significant improvement in left ventricular function was seen in either the VEGF or control group.CONCLUSIONS:Transmyocardial delivery of rAAV2-VEGF(165) resulted in VEGF gene expression for at least three months and stimulated angiogenesis and arteriogenesis in porcine model of chronic myocardial ischemia. Myocardial perfusion was also improved after VEGF gene delivery.

Superior Neovascularization and Muscle Regeneration in Ischemic Skeletal Muscles Following VEGF Gene Transfer by Raav1 Pseudotyped Vectors

621. Angiogenesis and Arteriogenesis in Ischemic Skeletal Muscles Following VEGF Gene Transfer by Adeno-Associated Virus Serotype 1 Vectors

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

The Safety Assessment of Gene Transfer Mediated by the New Recombinant Adeno-Associated Virus Serotype 1 Pseudotyped Vector in Mouse Ischemic Lamb Model

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

Recombinant Adeno-Associated Viral Vector 2-Mediated Gene Transfer of VEGF165 Improved Porcine Chronic Myocardial Ischemia

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

637. Recombinant Adeno-Associated Viral Vector 2-Mediated Gene Transfer of VEGF Induces Neovascular Formation and Improves Blood Flow in Chronic Ischemic Swine Myocardium

Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain.

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy

Angiopoiesis and Bone Regeneration Via Co-Expression of the Hvegf and Hbmp Genes from an Adeno-Associated Viral Vector in Vitro and in Vivo.

Direct Myocardial Injection of Recombinant Adeno-Associated Viral Vector 2-Mediated VEGF165 Gene Induces Neovas-Cular Formation in Chronic Ischemic Swine Myocardium

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Adeno‐associated Virus Vectors for Gene Therapy—focusing on Melanoma

Effects of Recombinant Adeno-Associated Viruses Expressing Human Vascular Endothelial Growth Factor 165 on Spinal Cord Injury

Vascular Endothelial Grow Factor 165 and Angiopoitin-1 Augment Revascularization in a Rat Hindlimb Ischemia Model

[Study on Biological Activity of Recombinant Adeno-Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor 165 and Human Bone Morphogenetic Protein 7 Genes in Vitro].

Neuraminidase-mediated Desialylation Augments AAV9-mediated Gene Expression in Skeletal Muscle